GGrantIndex
Sort

53,477 grants matching addiction

NICOTINIC CHOLINERGIC SYSTEMS IN MUTANT MICE

$1,101,065
Baylor College Of Medicine · P01 · FY2002 · DA

Integrative Neuroscience Initiative on Alcoholism

$1,100,894
Marisa Roberto · Scripps Research Institute, The · U24 · FY2015 · AA

Physicians Outreach: Research to Practice

$1,100,870
Susan Hayashi · Johnson, Bassin And Shaw, Inc. · N01 · FY2010 · DA

Molecular Genetic Mapping of the Mouse Brain

$1,100,698
Merck And Company · R01 · FY2002 · MH

Functional Magnetic Resonance Imaging Of Emotion As Related To Alcoholism

$1,100,441
Daniel W Hommer · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA

Peripheral FAAH as a target for novel analgesics

$1,100,244
Daniele Piomelli · Anteana Therapeutics, Inc. · R42 · FY2017 · DA

MOLECULAR NEUROBIOLOGY OF DRUG ADDICTION

$1,100,227
University Of Texas Sw Med Ctr/Dallas · P01 · FY2001 · DA

Basic Research Center on Molecular and Cell Biology of Drug Abuse

$1,100,103
Horace H Loh · University Of Minnesota · P50 · FY2008 · DA

Staffing and Supports for Implementing Cross-System Interventions with Peer Mentors

$1,100,084
Alicia C Bunger · Ohio State University · R33 · FY2025 · DA

Neuroimaging of Brain Circuits and Neurogenetic Mechanisms in Normal Cognition

$1,099,384
Karen Faith Berman · National Institute Of Mental Health · Z01 · FY2008 · MH

Dynamic Signal Processing Analyses of Neural Plasticity

$1,098,919
Massachusetts General Hospital · R01 · FY2002 · DA

COBRE Transitional Center in Neuroscience

$1,098,750
George A Spirou · West Virginia University · P30 · FY2010 · RR

Modeling Inter-individual Differences to Address Pain of Sickle cell disease (MIDAS)

$1,098,640
Renee Manworren · University Of Texas Arlington · R01 · FY2025 · HL

Pharmacokinetics And Pharmacodynamics Of Smoked Drugs Of Abuse

$1,098,585
Marilyn A Huestis · National Institute On Drug Abuse · ZIA · FY2012 · DA

Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder

$1,097,854
Milton L Greenberg · Vivreon Biosciences, Llc · R44 · FY2025 · DA

Endocannabinoid Active Sites as Therapeutic Targets

$1,097,826
Alexandros Makriyannis · Northeastern University · P01 · FY2009 · DA

Long-lasting cocaine-metabolizing enzyme for cocaine addiction treatment

$1,097,704
Chang-Guo Zhan · University Of Kentucky · R01 · FY2014 · DA

Clinical Trials Network: Southwest Node

$1,097,298
Michael Parks Bogenschutz · University Of New Mexico · U10 · FY2013 · DA

Appalachian Tri-State Node

$1,096,827
Dennis C Daley · University Of Pittsburgh At Pittsburgh · U10 · FY2013 · DA

Models of SBIRT for Opioid Dependent Patients in the Emergency Department

$1,096,403
Gail D'onofrio · Yale University · R01 · FY2010 · DA

Dissemination of MAPseq and BARseq for high-throughput brain mapping

$1,095,906
Anthony M Zador · Cold Spring Harbor Laboratory · U24 · FY2022 · NS

Molecular profile of proviral reservoirs in HIV-infected drug users

$1,095,905
Xu Yu · Massachusetts General Hospital · R61 · FY2018 · DA

Brain Temperature, Reward, And Drugs Of Abuse

$1,095,822
Eugene A Kiyatkin · National Institute On Drug Abuse · Z01 · FY2008 · DA

Intracranial Drug Self-administration

$1,095,822
Satoshi Ikemoto · National Institute On Drug Abuse · Z01 · FY2008 · DA

Pharmacokinetics And Pharmacodynamics Of Smoked Drugs Of Abuse

$1,095,691
Marilyn A Huestis · National Institute On Drug Abuse · ZIA · FY2011 · DA